Therapies from Thiopeptides
The first part of this contribution describes solutions that were developed to achieve progressively more efficient syntheses of the thiopeptide natural products, micrococcins P1 and P2 (MP1–MP2), with an eye toward exploring their potential as a source of new antibiotics. Such efforts enabled inves...
Main Authors: | Hee-Jong Hwang, Marco A. Ciufolini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/22/7579 |
Similar Items
-
Nitro-Group-Containing Thiopeptide Derivatives as Promising Agents to Target <i>Clostridioides difficile</i>
by: Dahyun Kim, et al.
Published: (2022-05-01) -
High Prevalence of <i>Clostridioides difficile</i> Ribotype 176 in the University Hospital in Kosice
by: Katarina Curova, et al.
Published: (2023-03-01) -
Microbiota in <i>Clostridioides difficile</i>-Associated Diarrhea: Comparison in Recurrent and Non-Recurrent Infections
by: Alessandra Gazzola, et al.
Published: (2020-09-01) -
A Strong Synergy Between the Thiopeptide Bacteriocin Micrococcin P1 and Rifampicin Against MRSA in a Murine Skin Infection Model
by: Kirill V. Ovchinnikov, et al.
Published: (2021-07-01) -
In vitro and intracellular activities of novel thiopeptide derivatives against macrolide-susceptible and macrolide-resistant Mycobacterium avium complex
by: Jiyun Park, et al.
Published: (2023-10-01)